8-K

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 or 15(d) of
                      the Securities Exchange Act of 1934

                               September 30, 2003
                       (Date of earliest event reported)


                              RAYOVAC CORPORATION
     --------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

          Wisconsin                    001-13615                22-2423556
   ----------------------      ----------------------    ----------------------
(State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
     of incorporation)                                     Identification No.)

                  601 Rayovac Drive, Madison, Wisconsin 53711
          (Address of principal executive offices, including zip code)

                                 (608) 275-3340
              (Registrant's telephone number, including area code)

                                 Not applicable

     --------------------------------------------------------------------
         (Former name or former address, if changed since last report)
     --------------------------------------------------------------------


Item 5.       Other Events.

              On September 30, 2003, Rayovac Corporation issued a press
              release, attached hereto as Exhibit 99.1, which press release is
              incorporated herein by reference.

Item 7.       Financial Statements, Pro Forma Financial Information
              and Exhibits.

(c)           Exhibits

99.1          Press Release issued by Rayovac Corporation dated
              September 30, 2003.


                                   SIGNATURES

                  Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.


                                             RAYOVAC CORPORATION

Date: September 30, 2003                     By: /s/ Randall J. Steward
                                                 ----------------------
                                                 Randall J. Steward
                                                 Executive Vice President and
                                                 Chief Financial Officer



                                 EXHIBIT INDEX

EXHIBIT NUMBER                    DESCRIPTION OF EXHIBIT

99.1                              Press release dated September 30, 2003
                                  issued by Rayovac Corporation.

EX-99

                                                                  EXHIBIT 99.1

PRESS RELEASE

                      RAYOVAC CLOSES REMINGTON TRANSACTION
                               SEPTEMBER 30, 2003
                           JOHN DAGGETT, 608-275-4912

                      RAYOVAC CLOSES REMINGTON TRANSACTION

MADISON, WIS., (September 30, 2003) - Rayovac (NYSE: ROV) of Madison, Wis.
today announced the completion of its previously announced (August 22, 2003)
acquisition of Remington Products Company, LLC.

Rayovac also closed its previously disclosed private placement of $350 million
of 8 1/2% senior subordinated notes due 2013. Rayovac also announced that it is
calling for redemption all of the 11% Series B and Series D Senior Subordinated
Notes issued by Remington Products Company and Remington Capital Corp. which
have not been tendered by the close of Rayovac's outstanding offer to purchase
the notes.

Certain matters discussed in this news release, with the exception of
historical matters, are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These statements are subject
to a number of risks, uncertainties and other factors that could cause results
to differ materially from those anticipated as of the date of this release.
Actual results may differ materially from these statements as a result of (1)
changes in external competitive market factors, such as introduction of new
product features or technological developments, development of new competitors
or competitive brands or competitive promotional activity or spending, (2)
changes in consumer demand for the various types of products offered by Rayovac
or Remington, (3) changes in the general economic conditions where we do
business, such as stock market prices, interest rates, currency exchange rates,
inflation and raw material costs, (4) our ability to successfully implement
manufacturing, distribution and other cost efficiencies, (5) our ability to
obtain the regulatory approvals and financing necessary to close the Remington
transaction and (6) various other factors, including those discussed herein and
those set forth in Rayovac's and Remington's most recent Form 10-Q, Annual
Report on Form 10-K and the prospectus supplement for Rayovac's most recent
offering of its common stock.